Highlights Strength of Platform and Track Record of Execution and Value Creation
BANNOCKBURN, Ill., June 26, 2023 /PRNewswire/ — Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ:OPCH) today announced that it has terminated its previously announced agreement to combine with Amedisys, Inc. (“Amedisys”).
As part of the mutual termination agreement, Option Care Health will receive a $106 million termination fee. Consistent with Option Care Health’s commitment to creating shareholder value, the Company will incorporate the termination fee into its established capital allocation strategy.
“While we are disappointed in this outcome, Option Care Health has a long track record of delivering value for our shareholders,” said John C. Rademacher, President and Chief Executive Officer of Option Care Health. “We take a disciplined approach to acquisitions and, as we evaluated our options, we applied this discipline to ensure we continue to create value for all of our key stakeholders.”
“Option Care Health benefits from a leading platform in home and alternate site infusion services and a proven track record of execution,” Rademacher continued. “We remain confident in our growth trajectory, which is underpinned by current industry trends and market forces as well as our strong financial position. Our team is committed to serving all our stakeholders by providing unsurpassed care and superior clinical outcomes in the home or ambulatory setting, and we will continue to identify ways to increase the value we can deliver.”
